tiprankstipranks
Trending News
More News >
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market
Advertisement

TME Pharma N.V. (ALTME) Income Statement

Compare
3 Followers

TME Pharma N.V. Income Statement

Last quarter (Q4 2024), TME Pharma N.V.'s total revenue was €19.00K, an increase of Infinity% from the same quarter last year. In Q4, TME Pharma N.V.'s net income was €-2.47M. See TME Pharma N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 19.00K€ 17.00K€ 0.00€ 33.00K€ 35.00
Gross Profit
€ -78.00K€ -127.00K€ -92.00K€ -65.97K€ -62.97K
Operating Expenses
€ 5.20M€ 5.50M€ 12.00M€ 13.45M€ 5.83M
Depreciation and Amortization
€ 17.00K€ 144.00K€ 92.00K€ 66.00K€ 63.00K
EBITDA
€ -5.25M€ -5.07M€ -11.63M€ -12.88M€ -5.29M
Operating Income
€ -5.28M€ -5.62M€ -12.03M€ -13.27M€ -5.77M
Other Income/Expenses
€ -445.00K€ -1.11M€ -3.10M€ -1.19M€ -4.64M
Pretax Income
€ -5.72M€ -6.73M€ -15.13M€ -14.45M€ -10.41M
Net Income
€ -5.72M€ -6.74M€ -15.13M€ -14.45M€ -10.40M
Per Share Metrics
Basic EPS
€ -0.21€ -1.34€ -12.86€ -21.90€ -32.16
Diluted EPS
€ -0.21€ -1.34€ -12.86€ -21.90€ -32.16
Weighted Average Shares Outstanding
27.35M 5.02M 1.18M 659.00K 323.00K
Weighted Average Shares Outstanding (Diluted)
27.35M 5.02M 1.18M 659.85K 323.59K
Currency in EUR

TME Pharma N.V. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis